Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-029352

Chief Financial Officer sold 12,400 shares at $9.00 ($111,600)

  • Chief Financial Officer acquired 12,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BLOCH KATHLEEN P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-16 Exercise or conversion : show line 1 in the form +12,400 $4.69 $58,156 265,704 D
2018-05-16 Sale : show line 2 in the form −12,400 $9.00 $111,600 253,304 D
Open-market sales · 12,400 sh · avg $9.00 · $111,600

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −12,400 0 D
Loading xslF345X03/tv494430_4.xml…